Roivant Sciences (NASDAQ:ROIV) Earns Buy Rating from HC Wainwright
Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They currently have a $18.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 72.41% from the company’s previous close. Separately, Cantor Fitzgerald […]
Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They currently have a $18.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 72.41% from the company’s previous close. Separately, Cantor Fitzgerald […]
